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The role of Nox2-derived ROS in the development
of cognitive impairment after sepsis
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Hugo C Castro-Faria-Neto3, Fernando Q Cunha4, Luiz RG Britto1 and Fernando A Bozza5,7*
Abstract
Background: Sepsis- associated encephalopathy (SAE) is an early and common feature of severe infections.
Oxidative stress is one of the mechanisms associated with the pathophysiology of SAE. The goal of this study was
to investigate the involvement of NADPH oxidase in neuroinflammation and in the long-term cognitive impairment
of sepsis survivors.
Methods: Sepsis was induced in WT and gp91phox knockout mice (gp91phox−/−) by cecal ligation and puncture (CLP)
to induce fecal peritonitis. We measured oxidative stress, Nox2 and Nox4 gene expression and neuroinflammation in
the hippocampus at six hours, twenty-four hours and five days post-sepsis. Mice were also treated with apocynin, a
NADPH oxidase inhibitor. Behavioral outcomes were evaluated 15 days after sepsis with the inhibitory avoidance test
and the Morris water maze in control and apocynin-treated WT mice.
Results: Acute oxidative damage to the hippocampus was identified by increased 4-HNE expression in parallel
with an increase in Nox2 gene expression after sepsis. Pharmacological inhibition of Nox2 with apocynin completely
inhibited hippocampal oxidative stress in septic animals. Pharmacologic inhibition or the absence of Nox2 in
gp91phox−/− mice prevented glial cell activation, one of the central mechanisms associated with SAE. Finally,
treatment with apocynin and inhibition of hippocampal oxidative stress in the acute phase of sepsis prevented the
development of long-term cognitive impairment.
Conclusions: Our results demonstrate that Nox2 is the main source of reactive oxygen species (ROS) involved in the
oxidative damage to the hippocampus in SAE and that Nox2-derived ROS are determining factors for cognitive
impairments after sepsis. These findings highlight the importance of Nox2-derived ROS as a central mechanism
in the development of neuroinflammation associated with SAE.
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Introduction
The clinical observation that sepsis and systemic inflam-
mation affect brain function is not novel [1-3]. However,
it was only recently demonstrated that acute brain dys-
function is an independent cause of morbidity and mor-
tality in septic patients [4]. The presence of acute brain
dysfunction is a determining factor for long-term cogni-
tive impairments among sepsis survivors. Clinical studies
have shown that up to 60% of sepsis survivors exhibit
permanent cognitive deficits and memory loss [5].
Sepsis- associated encephalopathy (SAE) and its long-
term consequences in cognitive function are still poorly
understood. The use of relevant preclinical models has
facilitated the elucidation of central mechanisms, such
as mitochondrial and vascular dysfunction, neurotrans-
mission disturbance, inflammation and cell death [6-8].
Some studies have addressed the involvement of reactive
oxygen species (ROS), reduced antioxidant capacity, and
the accumulation of oxidative stress markers in experi-
mental sepsis [9-11] and in patients [12-17]. Mitochon-
dria are major sources of intracellular ROS and recent
studies support the importance of mitochondrial ROS
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for immune cell function [18,19]. However, the extent to
which mitochondria generate ROS in vivo is still contro-
versial [20]. Another main source of ROS in the brain is
NADPH oxidase.
NADPH oxidases are a family of enzymes dedicated to
the generation of ROS (O2 · −) via reduction of molecu-
lar oxygen [21,22]. Members of the NADPH oxidase
family include Nox1 through 5 as well as Dual oxidase 1
and 2 (Duox 1 and Duox 2). In the nervous system, the
main isoforms are Nox1, Nox2 and Nox4 [23]. These
isoforms have been identified in different cell types, in-
cluding neurons, endothelial and glial cells [24]. More-
over, NADPH oxidase isoforms are activated by various
stimuli, including damage-associated and pathogen-
associated molecular patterns (DAMPs and PAMPs),
inflammatory mediators and neurotoxins. NADPH oxidase
dependent production of O2·− has been identified as a
major contributor to brain injury in cerebral ischemia
[25-27], excitotoxicity [28], Alzheimer’s disease, Parkinson’s
disease and other neurological diseases [29].
Here we explored the role of NADPH oxidase in differ-
ent aspects of the pathophysiology of SAE. We investigated
the involvement of NADPH oxidase in neuroinflammation
and in the long-term cognitive impairment of sepsis survi-
vors. Our approach included pharmacological inhibition of
NADPH oxidase activity with apocynin, as well as the use
of genetically deficient (knockout) mice for gp91phox
(gp91phox−/−), the catalytic subunit of Nox2. We identified
Nox2 as a necessary step for glial cell activation in SAE
and as a major source of oxidative stress and cognitive
impairment in sepsis survivors.
Material and methods
Animals
Adult male C57BL/6 (wild-type (WT)) (eight to ten
week-old, 25 to 30 g) were obtained from the Oswaldo
Cruz Foundation (FIOCRUZ), and from the Institute of
Biomedical Sciences, University of São Paulo breeding
units. Gp91phox−/− mice were obtained from Jackson
Laboratories (Bar Harbor, ME, USA). The animals had free
access to food and water and were maintained on a 12:12
hour light–dark cycle. Experiments were performed with
age- and weight-matched animals. All procedures were ap-
proved by the Institutional Animal Care Committees of
the Institute of Biomedical Sciences, University of São
Paulo and the FIOCRUZ, Rio de Janeiro, Brazil.
Sepsis model
Sepsis was induced by cecal ligation and puncture
(CLP), a procedure that generates an acute polymicrobial
peritonitis as previously described [30]. Mice were anes-
thetized with an intraperitoneal (ip) injection of keta-
mine (100 mg/kg) and xylazine (10 mg/kg) and a 1 cm
incision was made on the abdomen. The cecum was
exposed and ligated below the ileocecal junction. A
double puncture was made using a 22-gauge needle, to
induce mild sepsis. Sham-operated animals (controls)
underwent an identical laparotomy but without CLP.
Alternatively, experimental sepsis was induced by an ip
injection of the fecal slurry, which induces acute polymi-
crobial peritonitis and a septic syndrome similar to CLP.
Both models show similar inflammatory response profiles
in terms of mortality, blood cytokines and neuroinflam-
mation (data not shown). The intraperitoneal injection of
the fecal slurry model was chosen for behavioral studies
to avoid surgery and the use of anesthetics that might
affect pathways involved in cognitive impairment induced
by sepsis. All mice received antibiotic therapy by subcuta-
neous injection of ertapenem or meropenen (20 mg/kg)
(Merck Research Laboratory, Whitehouse Station, NJ,
USA) beginning six hours after sepsis induction and then
every twelve hours up to day four. Animals received 1 ml
of sterile saline subcutaneously (sc) as fluid resuscitation
after sepsis induction.
Apocynin treatment
Apocynin has been widely used as a pharmacological
tool to inhibit NADPH oxidase activity [31,32]. Its
mechanism of action involves blocking the translocation
of the cytosolic subunit p47phox to the plasma mem-
brane, thereby inhibiting Nox2 activation [33]. Apocynin
treatment has shown anti-inflammatory effects in some
models of inflammatory diseases, such as rheumatoid
arthritis [34], Parkinson's disease [32], ALS [35] and
brain ischemia [36], as well as in our models of sepsis
(data not shown). To access the involvement of Nox2-
derived ROS in glial cell activation in the hippocampus,
WT mice were injected with 20 mg/kg of apocynin
(Sigma-Aldrich, St. Louis, MO, USA) sc 30 minutes
prior to the induction of sepsis. Tissue samples were
collected at six hours, twenty-four hours and five days
post-sepsis for immunoblotting, immunohistochemistry
and real-time PCR analysis. To test the effects of Nox2
inhibition on behavioral outcomes, sham and septic mice
were treated with 5 mg/kg of apocynin sc beginning one
hour after sepsis onset and at 6, 24 and 48 hours post-
sepsis. Apocynin did not affect mortality or severity
scores of treated mice (data not shown).
Real-time PCR
Hippocampi from sham (n = 8) and septic (n = 8) mice
were directly homogenized in 1 ml TRIzol (Invitrogen,
Carlsbad, CA, USA) and total RNA was isolated follow-
ing the manufacturer's suggested protocol. PCR reac-
tions were performed, recorded, and analyzed using the
Corbett Research system (Corbett Life Sciences, Sydney,
Australia). The specificity of the SYBR® green assay was
confirmed by melting-point analysis. Expression data were
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calculated from the cycle threshold (Ct) value using
the ΔCt method for quantification [37]. Gene expres-
sion of GAPDH mRNA (sense: 5′-GTGCAGTGCCA
GCCTCGTCC-3′; antisense: 5′- CAGGCGCCCAATA
CGGCCAA-3′) was used for normalization. The results
were expressed as percent increases. All oligonucleotides
and reagents utilized in this protocol were purchased from
Invitrogen, Carlsbad, CA, USA. Sequences used were:
Nox2 (sense: 5’-TCAAGACCATTGCAAGTGAACAC-3’;
antisense: 5’-TCAGGGCCACACAGGAAAA-3’) and Nox4
(sense: 5’- TGGGCGTCCTCGGTGGAAACT-3’; anti-
sense: 5’- TGGGTCCACAGCAGAAAACTCCA-3’).
Measurement of oxidative stress
Oxidative stress was assessed by Western blotting for 4-
hydroxynonenal, a marker of tissue oxidative stress [38].
Mice were deeply anesthetized with isoflurane; the
hippocampi were collected at different time points after
sepsis induction and immediately frozen in dry ice. The
tissue was homogenized in ice-cold Tris–HCl buffer
containing protease and phosphatase inhibitor cocktails
(Complete, Roche, Indianapolis, IN, USA). Protein con-
centration was measured with a BCA protein assay kit
(Thermo Fisher Scientific, Waltham, MA, USA). Protein
electrophoresis was made in Polyacrylamide 4 to 15%
gradient gels (Pre-cast, BioRad, Hercules, CA, USA) and
proteins were transferred to PVDF Immobillon-FL
membranes (Millipore, MA, USA). Membranes were
blocked with Odyssey Blocking Buffer reagent (Li-Cor
Biosciences, Lincoln, NE, USA) and incubated overnight
with a mouse monoclonal antibody anti-HNE (1:500,
Abcam, Cambridge, MA, USA) and a rabbit polyclonal
anti-cyclophilin B (1:5,000; Pierce Biotechnology, Inc.
Rockford, IL, USA); the latter was used as a loading con-
trol as described elsewhere [39]. After washing with PBS,
membranes were incubated with IRDye secondary anti-
bodies (Li-Cor Biosciences) for one hour. Immunoreac-
tivity was visualized with an Odyssey Infrared Imaging
System (Li-Cor Biosciences, Lincoln, NE, USA). This sys-
tem allows multiplex detection of antigens in one mem-
brane using primary antibodies from different species,
without the need for membrane stripping.
Immunohistochemistry
Mice were deeply anesthetized with isoflurane and sub-
jected to transcardial perfusion with a saline solution
followed by 4% paraformaldehyde (PFA) dissolved in
0.1 M PBS at pH 7.4. The brains were collected, post-
fixed in PFA overnight, and transferred to a 20% su-
crose solution for 48 hours to ensure cryoprotection. For
glial cell morphological studies, brain sections (40 μm)
were obtained in a cryostat (Leica Microsystems, Germany,
model CM1850) and stored floating in PBS. Sections were
incubated with a blocking buffer containing 0.3% Triton
X-100, 2% normal goat serum and 1% BSA for two hours.
Sections were then incubated overnight with a rabbit IgG
anti-ionized calcium binding adaptor molecule 1 (1:200;
Iba1; Wako Chemicals Inc., Richmond, VA, USA) or with
a rabbit IgG anti-glial fibrillary acidic protein (1:1,000;
GFAP; Millipore, MA, USA) diluted in blocking buffer.
Following three washes with PBS, sections were incu-
bated for two hours with a secondary antibody, Alexa
488 goat anti-rabbit IgG diluted 1:1,000 in blocking buf-
fer. After washing out the secondary antibody, sections
were mounted on slides with Vectashield Mounting
Media for Fluorescence with 4',6-diamidino-2-pheny-
lindole (DAPI) (Vector Laboratories, Burlingame, CA,
USA) for nuclear staining. Confocal images were obtained
with a confocal laser-scanning microscope (Leica Micro-
systems, Germany, model TCS SP5 AOBS) with a 63x oil
immersion objective.
For quantitative studies, 30 μm brain sections were in-
cubated free-floating for 12 to 16 hours with anti-OX42
(CD11b/c, Biosciences, San Jose, CA, USA) and anti-
GFAP (Immunon, Pittsburgh, PA, USA) diluted 1:1,000
in 0.3% of Triton X-100 containing 0.05% normal goat
serum. Following three washes of ten minutes each with
PBS, sections were incubated for two hours with a
biotinylated secondary antibody (donkey anti-mouse
IgG, Jackson ImmunoResearch, West Grove, PA, USA,
1:200), followed by the avidin-biotin complex (1:100;
ABC Elite kit, Vector Labs, Burlingame, CA, USA).
After washing, the sections were reacted with 0.05% 3,3-
diaminobenzidine and 0.01% hydrogen peroxide in PBS.
Intensification was conducted with 0.05% osmium tetrox-
ide in water. The sections were mounted on gelatinized
slides, dehydrated, cleared and cover-slipped. Controls
for immunostaining included the omission of the primary
antibody and its substitution for normal goat serum,
which completely eliminated staining. The material was
analyzed using a light microscope, and digital images
were semi-quantitatively analyzed using ImageJ software
(National Institutes of Health, USA). OX42 and GFAP
immunostaining were evaluated in terms of optical dens-
ity within 0.4 mm2 areas for the CA1, CA3 and DG
regions. The mean optical density of labeled areas was
compared with the mean density of neighboring, non-
labeled areas in the same sections, to obtain a labeling
index reflecting the mean signal-to-noise ratio as previ-
ously described [40].
Behavioral tests
Behavioral outcomes were evaluated 15 days after sepsis
onset. The step-down inhibitory avoidance test was per-
formed as we previously described [41]. In the training
trial, animals were placed on a platform and their la-
tency to step down on the grid with all four paws was
measured with an automatic device. Immediately upon
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stepping down on the grid, the animals received a
0.6 mA/3.0-second foot shock. A retention test trial was
performed 24 hours after training and duration on the
grid was recorded (cut-off of 180 seconds). The Morris
water maze has been extensively used to examine learn-
ing and memory deficits in many neurological disease
models. Damage to the hippocampus causes impairment
in spatial memory function in the water maze [42]. Ani-
mals were trained to find the platform for four days with
60-second trial sessions and their time to find the plat-
form was measured. On the fifth day, a trial in the ab-
sence of the platform was run and the exploration time
in the quadrant where there was previously a platform
was measured and expressed as latency time.
MCP-1 and IL-1 measurements
The inflammatory response induced by sepsis was evalu-
ated by measuring the levels of monocyte chemoattract-
ant protein (MCP)-1 and IL-1 in the plasma and in the
peritoneal cavity using an ELISA method. Mice were
killed in a carbon dioxide chamber six hours after sepsis
onset, and the peritoneal cavity was opened and rinsed
with 3 ml of PBS solution. The peritoneal fluid was col-
lected for determination of cytokines levels. Blood sam-
ples were collected from a peripheral vein and kept on
ice. Plasma was collected by centrifugation at 800 g for
15 minutes at 4°C, aliquoted, and stored at −70°C until
the analysis day. All measurements were performed fol-
lowing the manufacturer’s instructions (R&D systems
Duo set kit, Minneapolis, MN, USA).
Statistical analysis
The results are presented as the mean ± standard error
of the mean (SEM). Statistical analyses of data were gen-
erated using GraphPad Prism, version 3.02 (GraphPad
Software Inc., San Diego, CA, USA). Statistical compari-
sons of more than two groups were performed using an
analysis of variance (ANOVA) and were analyzed by the
Mann–Whitney U-test or the Kruskal-Wallis test. In all
cases, P ≤ 0.05 was considered statistically significant.
Results
Oxidative stress in the hippocampus is associated with
Nox2 expression
To evaluate oxidative damage in the hippocampus of septic
mice, we measured the expression of 4-hydroxynonenal (4-
HNE), a by-product of lipid peroxidation. We observed a
progressive increase in 4-HNE levels in the hippocampus
early after sepsis that was accompanied by a significant in-
crease in Nox2 gene expression. 4-HNE was detected at six
hours, twenty-four hours, and up to five days post-sepsis
(Figure 1A). Real-time PCR analysis revealed that Nox2
gene expression was significantly induced in the hippocam-
pus at twenty-four hours and five days, while Nox4 was not
significantly changed, indicating that Nox2 is associated
with brain oxidative stress in SAE (Figure 1B, C). To clarify
the role of Nox2 in the oxidative damage in SAE, we
treated mice with apocynin. The treatment with apocynin
prevented the 4-HNE increase in the hippocampus in-
duced by sepsis (Figure 2A), indicating that Nox2 must be
a major contributor to hippocampal ROS generation in
SAE.
Apocynin modulates neuroinflammation in
sepsis- associated encephalopathy (SAE) by
inhibiting astrogliosis
Six hours after sepsis onset there is already a significant
activation of astrocytes and microglia in WT animals.
Activated microglia presented increased Iba1 immu-
noreactivity and hypertrophic morphology (Figure 2B).
Astrocytes activation presented thickening of cellular pro-
cesses and increased expression of GFAP (Figure 2C). As-
trocytes and microglia were affected in different ways by
apocynin treatment. Astrocyte activation was inhibited by
apocynin, whereas microglia activation was not affected
(Figure 2).
Microglia and astrocyte activation were more pro-
nounced five days after sepsis onset, so we performed
quantification of glial cells activation in different regions
of the hippocampus at this time point to confirm the
morphological findings. Microglial activation was more
prominent within the CA1 and DG regions (CA1 circa
146%; CA3 circa 73%; and DG circa 151%). Apocynin
treatment was not able to prevent microglial activation
induced by sepsis in CA1, CA3 and DG (Figures 3A, B,
C and 4A). Septic mice exhibited a significant increase
in the number of activated astrocytes with highly rami-
fied and thick processes (CA1 circa 87%; CA3 circa
163%; and DG circa 166% versus control). The treatment
with apocynin reversed astrocyte activation in all of the
hippocampal regions analyzed (CA1 circa 56%; CA3
circa 63%; and DG circa 56%, Figures 3D, E, F and 4B).
Neuroinflammation induced by sepsis- associated
encephalopathy (SAE) is impaired in Nox2 knockout mice
To further investigate the role of Nox2 in glial cell acti-
vation, we used gp91phox−/− mice and evaluated astrocyte
and microglia activation in different regions of the
hippocampus five days after sepsis. We observed no
discernible differences in CD11b or GFAP immuno-
staining between sham gp91phox−/− and septic gp91phox−/−
mice (Figure 5). These results indicate that, although
apocynin treatment did not prevent microglia activa-
tion, a functional Nox2 was necessary for microglia ac-
tivation in SAE. Astrocyte activation induced by sepsis
was also impaired in gp91phox−/− mice, indicating a
complete dependence of astrocytes on Nox2 in order to
become activated (Figure 5).
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Acute apocynin treatment prevents long-term cognitive
impairment after sepsis
To test the hypothesis that Nox-derived oxidative stress
determines behavioral outcomes in sepsis survivors, we
treated animals with low doses of apocynin (5 mg/kg)
throughout the acute phase of sepsis and performed be-
havioral tests to evaluate cognitive function in survivors
fifteen days after sepsis onset. Mice that survived sepsis
presented significantly lower latency time on the in-
hibitory avoidance test, but septic mice treated with
Figure 1 Oxidative stress in the hippocampus is associated with Nox2 expression after sepsis induction. Hippocampi from WT mice were
obtained at six hours, twenty-four hours and five days after sepsis onset. (A) Tissue oxidative stress was assessed by measuring 4-hydroxynonenal
(4-HNE) levels, expressed as the percent increase over sham. The bottom figure shows one representative Western blot with two bands per
experimental condition. (B) Nox2 and (C) Nox4 mRNA expression in the hippocampus after sepsis induction. White bars represent shams and
black bars represent sepsis. The statistical significance is expressed as: *P < 0.05 versus sham. n = 5 to 7 in each group. Cyc: cyclophilin B.
Figure 2 Apocynin treatment prevents oxidative stress and astrogliosis in the hippocampus early after sepsis. (A) WT mice were treated
with apocynin one hour after sepsis onset. Brain oxidative stress was measured six hours after sepsis onset. Values are ratios of 4-HNE/cyclophilin B
(a low molecular weight loading control) densitometry, expressed as mean ± SEM (n = 4 each group). The bottom figure shows two representative
bands of Sham, Sham+ Apo, Sepsis and Sepsis + Apo. The statistical significance is expressed as: *P < 0.05 and ***P < 0.001. (B) Representative digital
images of Iba-1 immunoreactivity (in green) in the CA1 region indicate that apocynin treatment did not affect microglia activation. (C) Representative
digital images of GFAP (in green) immunoreactivity in CA1 region indicate thickening of astrocyte processes, especially around blood vessels; apocynin
treatment decreased astrogliosis after sepsis. Nuclear 4',6-diamidino-2-phenylindole (DAPI) staining is shown in blue. Images are representative of three
independent experiments (n = 6 per experimental group). Apo: apocynin. Scale bar: 20μm.
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Figure 3 Apocynin treatment selectively inhibits astrocyte activation after sepsis. Effects of sepsis induction on OX42-like immunoreactivity
in CA1 (A), CA3 (B) and DG (C) and GFAP immunoreactivity in CA1 (D), CA3 (E) and DG (F) in the hippocampi of animals allowed to survive for
five days after sepsis onset. The graphs depict optical density data. In A, B and C, the statistical significance is expressed as: ***P < 0.001 and **P < 0.01
versus sham. In D, **P < 0.01 versus sham and **P < 0.01 versus sepsis. In E and F, ***P < 0.001 versus sham and ***P < 0.001 versus sepsis. n = 5 to 6 in
each case. DG: dentate gyrus.
Figure 4 Apocynin inhibits astrogliosis in the dentate gyrus of the hippocampus. Representative digital images of OX42-like immunoreactivity
(A) and GFAP-like immunoreactivity (B) in the dentate gyrus (DG) of the WT Sham, WT Sham apocynin, WT Sepsis, WT Sepsis apocynin groups analyzed
five days after sepsis onset.
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apocynin did not show any memory deficits in this
test (Figure 6A). In the Morris water maze test, sep-
sis survivors presented an increase in the time to
find the platform (Figure 6B) and spent less time in the
right quadrant (Figure 6C), whereas sham animals and
apocynin-treated mice all had better performances in
both tests (Figure 6). These results indicate that Nox2-
derived oxidative damage to the hippocampus is an
important factor implicated in the long-term cognitive
impairment associated with sepsis.
Systemic inflammation induced by sepsis is not
decreased by the pharmacological inhibition of Nox2
In order to investigate whether the protective effects ob-
served by the pharmacological inhibition of Nox2 on oxi-
dative stress, neuroinflammation and in the development
Figure 5 Absence of Nox2 prevents glial cell activation in gp91phox−/− mice. Effects of sepsis induction on OX42-like immunoreactivity in
CA1 (A), CA3 (B) and DG (C) and GFAP immunoreactivity in CA1 (E), CA3 (F) and DG (G) of gp91phox −/− mice in the hippocampi of animals
allowed to survive for five days after sepsis onset. The graphs show optical density data. n = 5 to 6 in each case. (D) Representative digital images
of OX42-like immunoreactivity into dentate gyrus (DG) in gp91phox−/− sham and gp91phox−/− sepsis mice. (H) Representative digital images of
GFAP-like immunoreactivity into DG in gp91phox−/− sham and gp91phox−/− sepsis mice.
Figure 6 Apocynin treatment prevents cognitive impairment after sepsis. Septic encephalopathy was induced in WT mice (n = 5 to 10/group)
via intraperitoneal inoculation with fecal slurry. The control group was injected with saline (0.9%). Mice were divided into two groups and treated with
apocynin (5 mg/kg body weight) one hour after feces injection and every 24 hours for 3 days. All the animals received imipenem (10 mg/kg body
weight) six hours after infection and every 24 hours for 3 days. (A) Step-down inhibitory avoidance test. Aversive memory was tested 24 hours after
training by recording the latency time on the platform (with a cut-off of 180 seconds). Data are expressed as individual values and horizontal lines
represent the mean latency in seconds; significant differences were found between sham versus septic mice (Mann–Whitney U-test, *P < 0.05). Spatial
memory impairment was evaluated with the Morris water maze. (B) Time to find the platform. Student t-test, *P < 0.05. (C) Trial in the absence of
platform. Latency represents the exploration on the quadrant where the platform was before removal. Student t-test, *P < 0.05.
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of long-term cognitive impairment were secondary to a de-
creased systemic inflammation, animals were treated with
apocynin and cytokines levels were measured after sepsis
induction. We specifically investigated the ability of apocy-
nin to decrease MCP-1 and IL-1 levels in plasma and
in peritoneal fluid six hours after sepsis onset. As shown in
Figure 7A and B, we observed a significant increase in
MCP-1 levels in both plasma and in peritoneal fluid after
sepsis onset, which was not inhibited by apocynin treat-
ment. IL-1 levels were found significantly increased only in
peritoneal fluid (Figures 7C and D). Similarly, apocynin
treatment was not able to significantly inhibit IL-1 in-
creased levels. These results suggest that the apocynin
treatment was not able to prevent systemic inflammation
induced by sepsis as opposed as its central effects.
Discussion
The results presented in this study provide evidence that
Nox2 is the main source of ROS involved in the oxida-
tive damage to the hippocampus in SAE and that Nox2-
derived ROS are determining factors for cognitive
impairments after sepsis. There are numerous experi-
mental findings that support these conclusions. First,
there is a progressive oxidative damage to the hippo-
campus, identified by increased 4-HNE expression, as-
sociated with an increase in Nox2 gene expression in
the first days after sepsis. Second, pharmacological in-
hibition of Nox2 with apocynin completely inhibits hip-
pocampal oxidative damage in septic animals. Third,
pharmacological inhibition or the absence of Nox2 in
gp91phox−/− mice prevents glial cell activation, one of
the central mechanisms associated with SAE and other
neurodegenerative diseases [43-45]. Finally, treatment
with apocynin in the acute phase of sepsis prevents the
development of long-term cognitive impairment in the
survivors. Our results confirm previous findings that
oxidative damage to the hippocampus is involved in the
development of cognitive impairment in SAE. These re-
sults also highlight the importance of Nox2-derived
ROS as a central mechanism in glial cells activation
and identify Nox2 as a potential target for future ther-
apies to prevent SAE.
Sepsis-induced organ dysfunction has been attributed
to a tissue adaptation to systemic inflammation, which
involves mitochondrial dysfunction, oxidative stress and
bioenergetics impairments [46,47]. Evidence from the
Figure 7 Systemic inflammation induced by sepsis is not affected by the pharmacological inhibition of Nox2. Effects of sepsis induction
on MCP-1 and IL-1 levels in the plasma and peritoneal fluid of WT animals treated with apocynin. Mice were allowed to survive for six hours after
sepsis onset. All concentrations were expressed in pg/ml. The statistical significance is expressed as: ***P < 0.001; n = 6 to 10 for each experimental
group tested.
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literature supports the hypothesis that alterations in
mitochondrial function may increase O2·− generation as
a byproduct of the electron transport chain, especially
O2·− derived from complex I [48-50]. However, the role
of complex I as the major site of ROS production in in-
tact mitochondria in the absence of respiratory chain in-
hibitors remain controversial. Previous studies from our
group demonstrated a reduction in oxidative phosphor-
ylation efficiency and complex IV activity in brain tissue
24 hours after sepsis onset in the CLP mouse model. In
this study, we were not able to detect mitochondrial
ROS production [47], suggesting that other pathways
could be responsible for the oxidative stress observed in
the brain tissue of septic rodents [9].
Increased NADPH oxidase activity has been impli-
cated in a variety of neurodegenerative conditions, such
as Parkinson’s and Alzheimer’s diseases (reviewed by
[23,29]). There is increasing evidence that aldehyde mol-
ecules generated endogenously during the process of
lipid peroxidation, such as 4-HNE, are causally involved
in most of the pathophysiological effects associated with
oxidative stress in vivo [38]. Therefore, we hypothesized
that ROS derived from NADPH oxidase is the main
cause of oxidative stress and brain dysfunction after sep-
sis. To test this hypothesis, we used pharmacological
inhibition of NADPH oxidase and genetic deletion of
the catalytic subunit gp91phox to evaluate the acute and
long-term outcomes of sepsis. Our data show that 4-
HNE levels are increased in the brains of septic mice,
beginning six hours and up to five days post-sepsis.
Real-time PCR analysis demonstrated that Nox2, but not
Nox4 mRNA, was induced in the hippocampus 24 hours
after sepsis, whereas oxidative stress was detected earlier
at six hours, suggesting that NADPH oxidase activity is
induced before the increase in gene expression. Treat-
ment with apocynin inhibited the oxidative stress at six
hours, indicating that it might be caused by an increase
in Nox2 enzyme activity. Apocynin reacts with the cyst-
eine residues of p47phox, a cytosolic component of the
complex, inhibiting its association with the Nox2-
p22phox heterodimer and, consequently, its enzyme
activity. The early increase in NADPH oxidase activity
followed by an increase in gene expression has been
demonstrated in other models of acute brain injury [51].
Thus, our data add to previous observations that mito-
chondria are not the main source of ROS in the nervous
system after sepsis induction, and a significant portion of
ROS production in the hippocampus under septic condi-
tions is attributable to Nox2.
Nox2 has been shown to regulate intracellular ROS
levels in microglia and to result in both amplification of
pro-inflammatory cytokines production and priming of
microglia to additional stimuli [52]. In vitro studies sug-
gested that the production of ROS from Nox2 is also es-
sential for the morphological activation of microglia in
both 6-hydroxidopamine and lipopolysaccharide (LPS)-
Parkinson’s disease models [53-55]. Our immunohisto-
chemistry data show the absence of microglia activation
in gp91phox−/− after sepsis induction, consistent with the
essential role of Nox2 in signaling microglia activation.
Figure 8 Summary of the main findings. This figure highlights the involvement of Nox2 in brain dysfunction associated to sepsis- associated
encephalopathy (SAE) and the long-term consequences. Nox2 activation is inhibited by apocynin, preventing ROS production without affecting
microglial activation. Gp91phox gene deletion impairs microglial activation after sepsis.
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Nevertheless, microglial activation was not prevented by
the NADPH oxidase inhibitor apocynin. One possibility
to explain this finding is that apocynin treatment does
not inhibit microglia activation, but alters its phenotype
to an anti-inflammatory M2-like phenotype, as recently
demonstrated by Choi and colleagues [56].
In contrast, astrocyte activation after sepsis was signifi-
cantly inhibited by a single dose of apocynin, suggesting
that Nox2-derived ROS played a role in the signaling
events leading to astrocyte activation after sepsis. Simi-
larly, it has been shown that ischemic animals treated
with apocynin showed significantly less reactive astro-
cytes compared to the non-treated group [57]. NADPH
oxidase activation in astrocytes may lead to oxidative
stress, glutathione depletion, and neuronal death [58,59].
Patients with chronic granulomatous disease (CGD),
an immunodeficiency syndrome caused by disabling mu-
tations of genes encoding the NADPH oxidase subunits
[60,61], have an increased susceptibility to fungal and
bacterial infections. Pre-clinical models using NADPH
oxidase-deficient mice [62,63] have shown intrinsic de-
fects in the control of inflammation. Han et al. (2013)
demonstrated that p47phox−/− mice have increased lung
inflammation after LPS instillation and that this effect is
due to increased NF-κB binding to DNA [64]. Therefore,
inhibition of NADPH oxidase may be protective to the
central nervous system, but may have deleterious effects
in the control of systemic inflammation and/or infection.
It is important to note that this does not seem to be
the case in our study, because we did not observe in-
creased mortality in apocynin-treated animals (data not
shown) and in the inflammatory response induced by
sepsis (as demonstrated by the evaluation of proinflam-
matory cytokines levels); this outcome may be explained
by the low doses used to block NAPDH oxidase in our
conditions.
Although there is enough evidence from the literature
that sepsis survivors develop cognitive impairments, the
molecular mechanisms of cognitive impairment in sep-
sis are far from understood. Several hypotheses were
created to explain the brain dysfunction associated with
sepsis, including neuroinflammation, neurotransmitter
disturbances, apoptosis, and oxidative stress. Evidence
from animal studies links oxidative damage and long-
term cognitive impairment. Barichello et al. (2007)
demonstrated that the administration of a combin-
ation of antioxidants, N-acetylcysteine plus deferoxamin,
in the acute phase of sepsis prevented long-term oxida-
tive damage [65]. In our study, we demonstrated that
Nox2-derived ROS are determinants of neuroinflam-
mation and of the development of long-term cogni-
tive impairment. Strategies to modulate Nox2 activity
may be useful in the future to prevent SAE development
(Figure 8).
Conclusions
The results of the present study demonstrate that Nox2
is essential for glial cell activation and emphasize the
critical role of oxidative damage and Nox2-derived ROS
as central factors contributing to acute and long-term
brain dysfunction after sepsis.
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